Tags

Type your tag names separated by a space and hit enter

Anti-IL6R role in treatment of COVID-19-related ARDS.
J Transl Med. 2020 04 14; 18(1):165.JT

Links

Publisher Full Text
ncbi.nlm.nih.gov
translational-medicine.biomedcentral.com
PMC Free PDF

Authors+Show Affiliations

Buonaguro FM
Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy.
Puzanov I
Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Ascierto PA
Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. paolo.ascierto@gmail.com.

MeSH

Antibodies, Monoclonal, HumanizedBetacoronavirusCOVID-19Coronavirus InfectionsHumansPandemicsPneumonia, ViralRespiratory Distress SyndromeSARS-CoV-2

Pub Type(s)

Editorial
Comment

Language

eng

PubMed ID

32290847

Citation

Buonaguro, Franco Maria, et al. "Anti-IL6R Role in Treatment of COVID-19-related ARDS." Journal of Translational Medicine, vol. 18, no. 1, 2020, p. 165.
Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R role in treatment of COVID-19-related ARDS. J Transl Med. 2020;18(1):165.
Buonaguro, F. M., Puzanov, I., & Ascierto, P. A. (2020). Anti-IL6R role in treatment of COVID-19-related ARDS. Journal of Translational Medicine, 18(1), 165. https://doi.org/10.1186/s12967-020-02333-9
Buonaguro FM, Puzanov I, Ascierto PA. Anti-IL6R Role in Treatment of COVID-19-related ARDS. J Transl Med. 2020 04 14;18(1):165. PubMed PMID: 32290847.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anti-IL6R role in treatment of COVID-19-related ARDS. AU - Buonaguro,Franco Maria, AU - Puzanov,Igor, AU - Ascierto,Paolo Antonio, Y1 - 2020/04/14/ PY - 2020/04/02/received PY - 2020/04/08/accepted PY - 2020/4/16/entrez PY - 2020/4/16/pubmed PY - 2020/4/18/medline KW - ARDS KW - COVID-19 KW - IL-6 KW - SARS-CoV-2 KW - Tocilizumab SP - 165 EP - 165 JF - Journal of translational medicine JO - J Transl Med VL - 18 IS - 1 SN - 1479-5876 UR - https://www.unboundmedicine.com/medline/citation/32290847/Anti_IL6R_role_in_treatment_of_COVID_19_related_ARDS_ L2 - https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02333-9 DB - PRIME DP - Unbound Medicine ER -